Search
for
Sort by
Research 31–60 of 1000+
- Alopecia en mujeres con obesidad severa y mórbida sometidas a cirugía bariátrica
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Application of Baricitinib in Dermatology
- Lipid loses and barrier function modifications of the brown‐to‐white hair transition
- Baricitinib for the treatment of alopecia areata in adults: Real-world analysis of 36 patients
- Effect of Bariatric Surgery on Weight Loss, Nutritional Deficiencies, Postoperative Complications and Adherence to Dietary and Lifestyle Recommendations: A retrospective cohort study from Bahrain
- Epidermal PPARγ Is a Key Homeostatic Regulator of Cutaneous Inflammation and Barrier Function in Mouse Skin
- Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction?
- Emerging role of baricitinib in dermatology practice: All we need to know!
- Excellent Short- and Medium-term Result of Bariatric Surgery in Adolescence. A Single Center Study
- Post bariatric surgery complications, nutritional and psychological status.
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- The Complexities of Iron Deficiency in Patients After Bariatric Surgery
- Baricitinib for the Treatment of Alopecia Areata
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- Skin manifestations after bariatric surgery
- Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial
- Efficacy and safety of baricitinib in patients with refractory alopecia areata
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Skin manifestations of Bardet–Biedl syndrome
- Barraquer–Simons syndrome with benign infundibulocystic proliferation
- Comparison of Calcium and Barium Microcapsules as Scaffolds in the Development of Artificial Dermal Papillae
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- 34007 Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials